 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioRestorative Therapies (NASDAQ:BRTX  Get Free Report) and Sotera Health (NASDAQ:SHC  Get Free Report) are both medical companies, but which is the better investment? We will compare...

Financial Contrast: BioRestorative Therapies (NASDAQ:BRTX) vs. Sotera Health (NASDAQ:SHC)

MELVILLE, NY / ACCESSWIRE / September 18, 2023 / BioRestorative Therapies Inc. (NASDAQ:BRTX) ('BioRestorative') is a clinical-stage biotech company that is developing cell-based...

Roth MKM Analyst Projects An Impressive Price Target of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says Low Valuation Undeserved

--BioRestorative to Leverage its Core Competencies in Cell Biology and Manufacturing to Supply Biologics for Cosmetic Applications in Strategic Agreement --Agreement Represents Initial Venture...

BioRestorative Therapies Enters into Supply Agreement with Evolutionary Biologics

--Site activation allows for patients in the State of New York to participate in the BRTX-100 trial --15 Clinical Sites Identified, 12 of the 15 Activated and Recruiting Subjects MELVILLE...

BioRestorative Therapies Announces Activation of Northwell Health in the Company's Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease

MELVILLE, NY / ACCESSWIRE / August 30, 2023 / Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to experts, up to 80% of the...

As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs

Insider Buying Alert: Lance Alstodt Acquires 4200 Shares of BioRestorative Therapies Inc (BRTX)

MELVILLE, NY / ACCESSWIRE / July 21, 2023 / BioRestorative Therapies Inc. (NASDAQ:BRTX) ('BioRestorative'), a clinical-stage company specializing in stem cell-based therapies, has announced that it has been granted a license by the New York State Department of Health to operate as a...

BioRestorative Therapies (NASDAQ:BRTX) Receives Landmark License From New York State

MELVILLE, N.Y., July 11, 2023 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (BioRestorative, BRTX or the Company) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced it has entered into a definitive agreement with several accredited and institutional ...

BioRestorative Therapies Announces $2.1 Million Registered Direct Offering

BioRestorative Therapies Inc (NASDAQ: BRTX) shares are trading lower by 17.13% to $2.95 Tuesday after the company announced a $2.1 million registered direct offe
read more...

Why BioRestorative Therapies (BRTX) Stock Is Getting Hammered

MELVILLE, NY / ACCESSWIRE / July 7, 2023 / BioRestorative Therapies Inc. (NASDAQ:BRTX) has received a unanimous recommendation to proceed in its Phase 2 clinical trial for chronic lumbar disc disease, BRTX-100. The independent review body Data Safety Monitoring Board (DSMB) which is overseeing dose...

BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities

Biorestorative Therapies Inc. engages in developing therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders including obesity and diabetes. Its initial investigational therapeutic product being called BRTX-100 focuses on treating damage by autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process., The company was founded on June 13, 1997 and is headquartered in Melville, NY.

Watchers	3,204
52-Wk Low	$1.41
52-Wk High	$7.13

Market Cap	$8.36M
Volume (M)	65,473.00
52-Wk High	$7.13
52-Wk Low	$1.41

BRTX BioRestorative Therapies Inc

About

Feed

News

Fundamentals